comparemela.com
Home
Live Updates
From Calluna Pharmajan - Breaking News
Pages:
Latest Breaking News On - From calluna pharmajan - Page 1 : comparemela.com
Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases
Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).
Oxitope pharma
Calluna pharma
Calluna pharmajan
Calluna pharma inc
From calluna pharmajan
Arxx therapeutics
Chief executive officer
Immune system
Monoclonal antibody
vimarsana © 2020. All Rights Reserved.